{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:27:33Z","timestamp":1784744853197,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation Grant","award":["82200659"],"award-info":[{"award-number":["82200659"]}]},{"name":"National Natural Science Foundation Grant","award":["82002995"],"award-info":[{"award-number":["82002995"]}]},{"name":"Natural Science Foundation of Shandong Province Grant","award":["ZR2022QH002"],"award-info":[{"award-number":["ZR2022QH002"]}]},{"name":"Taishan Scholar Project special funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03387-5","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:28:53Z","timestamp":1763738933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Proteomics identifies complement protein signatures in patients with primary biliary cholangitis"],"prefix":"10.1186","volume":"30","author":[{"given":"Xiaolin","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junming","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1371-1712","authenticated-orcid":false,"given":"Meng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7413-080X","authenticated-orcid":false,"given":"Xiude","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4209-0718","authenticated-orcid":false,"given":"Luna","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1215-1661","authenticated-orcid":false,"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"12","key":"3387_CR1","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1056\/NEJMra043898","volume":"353","author":"MM Kaplan","year":"2005","unstructured":"Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med. 2005;353(12):1261\u201373. https:\/\/doi.org\/10.1056\/NEJMra043898. (Epub 2005\/09\/24.).","journal-title":"N Engl J Med"},{"key":"3387_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/hc9.0000000000000179","author":"J Trivella","year":"2023","unstructured":"Trivella J, John BV, Levy C. Primary biliary cholangitis: epidemiology, prognosis, and treatment. Hepatol Commun. 2023. https:\/\/doi.org\/10.1097\/hc9.0000000000000179. (Epub 2023\/06\/02).","journal-title":"Hepatol Commun"},{"key":"3387_CR3","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003174","author":"S Bhushan","year":"2024","unstructured":"Bhushan S, Sohal A, Kowdley KV, Agaf FF. Primary biliary cholangitis and primary sclerosing cholangitis therapy landscape. Am J Gastroenterol. 2024. https:\/\/doi.org\/10.14309\/ajg.0000000000003174. (Epub 2024\/10\/31).","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"3387_CR4","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/hep.0000000000000894","volume":"80","author":"Y Hitomi","year":"2024","unstructured":"Hitomi Y, Ueno K, Aiba Y, Nishida N, Kono M, Sugihara M, et al. A genome-wide association study identified PTPN2 as a population-specific susceptibility gene locus for primary biliary cholangitis. Hepatology. 2024;80(4):776\u201390. https:\/\/doi.org\/10.1097\/hep.0000000000000894. (Epub 2024\/10\/31).","journal-title":"Hepatology"},{"issue":"6","key":"3387_CR5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1053\/j.gastro.2024.01.049","volume":"166","author":"PJ Trivedi","year":"2024","unstructured":"Trivedi PJ, Hirschfield GM, Adams DH, Vierling JM. Immunopathogenesis of primary biliary cholangitis, primary sclerosing cholangitis and autoimmune hepatitis: themes and concepts. Gastroenterology. 2024;166(6):995\u20131019. https:\/\/doi.org\/10.1053\/j.gastro.2024.01.049. (Epub 2024\/02\/12).","journal-title":"Gastroenterology"},{"issue":"4","key":"3387_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5152\/tjg.2025.24300","volume":"36","author":"H Eruzun","year":"2025","unstructured":"Eruzun H, Bossen L, Turan G\u00f6k\u00e7e D, Ergen\u00e7 \u0130, Harput ZN, Aydemir NG, et al. Clinical and biochemical characteristics of a Danish and Turkish cohort of incident and prevalent patients with primary biliary cholangitis. Turk J Gastroenterol. 2025;36(4):241\u20136. https:\/\/doi.org\/10.5152\/tjg.2025.24300. (Epub 2025\/01\/06).","journal-title":"Turk J Gastroenterol"},{"issue":"5","key":"3387_CR7","first-page":"333","volume":"3","author":"X Qin","year":"2006","unstructured":"Qin X, Gao B. The complement system in liver diseases. Cell Mol Immunol. 2006;3(5):333\u201340 (Epub 2006\/11\/10).","journal-title":"Cell Mol Immunol"},{"issue":"2\u20133","key":"3387_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12026-013-8422-y","volume":"56","author":"E Ballanti","year":"2013","unstructured":"Ballanti E, Perricone C, Greco E, Ballanti M, Di Muzio G, Chimenti MS, et al. Complement and autoimmunity. Immunol Res. 2013;56(2\u20133):477\u201391. https:\/\/doi.org\/10.1007\/s12026-013-8422-y. (Epub 2013\/04\/26).","journal-title":"Immunol Res"},{"key":"3387_CR9","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1795143","author":"LG Prado","year":"2024","unstructured":"Prado LG, Nagy LE. Role of complement in liver diseases. Semin Liver Dis. 2024. https:\/\/doi.org\/10.1055\/s-0044-1795143. (Epub 2024\/11\/29.).","journal-title":"Semin Liver Dis"},{"issue":"6","key":"3387_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1600-0676.1993.tb00650.x","volume":"13","author":"P Garred","year":"1993","unstructured":"Garred P, Lyon H, Christoffersen P, Mollnes TE, Tranum-Jensen J. Deposition of C3, the terminal complement complex and vitronectin in primary biliary cirrhosis and primary sclerosing cholangitis. Liver. 1993;13(6):305\u201310. https:\/\/doi.org\/10.1111\/j.1600-0676.1993.tb00650.x. (Epub 1993\/12\/01).","journal-title":"Liver"},{"issue":"3","key":"3387_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1006\/clin.1998.4542","volume":"87","author":"M Gardinali","year":"1998","unstructured":"Gardinali M, Conciato L, Cafaro C, Crosignani A, Battezzati PM, Agostoni A, et al. Complement system is not activated in primary biliary cirrhosis. Clin Immunol Immunopathol. 1998;87(3):297\u2013303. https:\/\/doi.org\/10.1006\/clin.1998.4542. (Epub 1998\/07\/01).","journal-title":"Clin Immunol Immunopathol"},{"issue":"6","key":"3387_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102534","volume":"19","author":"M Biewenga","year":"2020","unstructured":"Biewenga M, Farina Sarasqueta A, Tushuizen ME, de Jonge-Muller ESM, van Hoek B, Trouw LA. The role of complement activation in autoimmune liver disease. Autoimmun Rev. 2020;19(6):102534. https:\/\/doi.org\/10.1016\/j.autrev.2020.102534. (Epub 2020\/04\/03).","journal-title":"Autoimmun Rev"},{"issue":"2","key":"3387_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/bf02918614","volume":"11","author":"M Schlesinger","year":"1992","unstructured":"Schlesinger M, Benbassat C, Shoenfeld Y. Complement profile in primary biliary cirrhosis. Immunol Res. 1992;11(2):98\u2013103. https:\/\/doi.org\/10.1007\/bf02918614. (Epub 1992\/01\/01).","journal-title":"Immunol Res"},{"issue":"3\u20134","key":"3387_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jaut.2009.09.010","volume":"33","author":"V Barak","year":"2009","unstructured":"Barak V, Selmi C, Schlesinger M, Blank M, Agmon-Levin N, Kalickman I, et al. Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis. J Autoimmun. 2009;33(3\u20134):178\u201382. https:\/\/doi.org\/10.1016\/j.jaut.2009.09.010. (Epub 2009\/10\/23.).","journal-title":"J Autoimmun"},{"issue":"11","key":"3387_CR15","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1002\/hep4.2067","volume":"6","author":"W Duan","year":"2022","unstructured":"Duan W, Chen S, Li S, Lv T, Li B, Wang X, et al. The future risk of primary biliary cholangitis (PBC) is low among patients with incidental anti-mitochondrial antibodies but without baseline PBC. Hepatol Commun. 2022;6(11):3112\u20139. https:\/\/doi.org\/10.1002\/hep4.2067. (Epub 2022\/08\/24.).","journal-title":"Hepatol Commun"},{"issue":"10457","key":"3387_CR16","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/s0140-6736(24)01303-5","volume":"404","author":"A Tanaka","year":"2024","unstructured":"Tanaka A, Ma X, Takahashi A, Vierling JM. Primary biliary cholangitis. Lancet. 2024;404(10457):1053\u201366. https:\/\/doi.org\/10.1016\/s0140-6736(24)01303-5. (Epub 2024\/09\/01.).","journal-title":"Lancet"},{"issue":"7982","key":"3387_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, Benner C, Hsu YH, Richardson TG, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023;622(7982):329\u201338. https:\/\/doi.org\/10.1038\/s41586-023-06592-6. (Epub 2023\/10\/05.).","journal-title":"Nature"},{"issue":"11","key":"3387_CR18","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1111\/liv.15720","volume":"43","author":"AH Jensen","year":"2023","unstructured":"Jensen AH, Winther-S\u00f8rensen M, Burisch J, Bergquist A, Ytting H, Gluud LL, et al. Autoimmune liver diseases and diabetes: a propensity score matched analysis and a proportional meta-analysis. Liver Int. 2023;43(11):2479\u201391. https:\/\/doi.org\/10.1111\/liv.15720. (Epub 2023\/09\/27.).","journal-title":"Liver Int"},{"issue":"2","key":"3387_CR19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/liv.14669","volume":"41","author":"J Lee","year":"2021","unstructured":"Lee J, Vali Y, Boursier J, Spijker R, Anstee QM, Bossuyt PM, et al. Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review. Liver Int. 2021;41(2):261\u201370. https:\/\/doi.org\/10.1111\/liv.14669. (Epub 2020\/09\/19.).","journal-title":"Liver Int"},{"issue":"2","key":"3387_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12016-021-08904-y","volume":"63","author":"F Colapietro","year":"2022","unstructured":"Colapietro F, Lleo A, Generali E. Antimitochondrial antibodies: from bench to bedside. Clinical Rev Allergy Immunol. 2022;63(2):166\u201377. https:\/\/doi.org\/10.1007\/s12016-021-08904-y. (Epub 2021\/09\/30).","journal-title":"Clinical Rev Allergy Immunol."},{"issue":"1","key":"3387_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1046\/j.1365-2249.1998.00707.x","volume":"114","author":"D Di Bona","year":"1998","unstructured":"Di Bona D, Montalto G, Clemenza L, Bascone F, Accardo P, Bellavia D, et al. Soluble complement receptor type 1 (sCR1) in chronic liver diseases: serum levels at different stages of liver diseases. Clin Exp Immunol. 1998;114(1):102\u20135. https:\/\/doi.org\/10.1046\/j.1365-2249.1998.00707.x. (Epub 1998\/10\/09.).","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"3387_CR22","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/hep.31419","volume":"73","author":"X Fan","year":"2021","unstructured":"Fan X, McCullough RL, Huang E, Bellar A, Kim A, Poulsen KL, et al. Diagnostic and prognostic significance of complement in patients with alcohol-associated hepatitis. Hepatology. 2021;73(3):983\u201397. https:\/\/doi.org\/10.1002\/hep.31419. (Epub 2020\/06\/20.).","journal-title":"Hepatology"},{"key":"3387_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2019.100017","volume":"2","author":"T Lung","year":"2019","unstructured":"Lung T, Sakem B, Risch L, W\u00fcrzner R, Colucci G, Cerny A, et al. The complement system in liver diseases: evidence-based approach and therapeutic options. J Transl Autoimmun. 2019;2:100017. https:\/\/doi.org\/10.1016\/j.jtauto.2019.100017. (Epub 2020\/08\/04.).","journal-title":"J Transl Autoimmun"},{"key":"3387_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1330095","volume":"15","author":"M Massri","year":"2024","unstructured":"Massri M, Toonen EJM, Sarg B, Kremser L, Grasse M, Fleischer V, et al. Complement C7 and clusterin form a complex in circulation. Front Immunol. 2024;15:1330095. https:\/\/doi.org\/10.3389\/fimmu.2024.1330095. (Epub 2024\/02\/09.).","journal-title":"Front Immunol"},{"issue":"1","key":"3387_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.0022-202X.2005.23673.x","volume":"125","author":"RD Sontheimer","year":"2005","unstructured":"Sontheimer RD, Racila E, Racila DM. C1q: its functions within the innate and adaptive immune responses and its role in lupus autoimmunity. J Invest Dermatol. 2005;125(1):14\u201323. https:\/\/doi.org\/10.1111\/j.0022-202X.2005.23673.x. (Epub 2005\/06\/29.).","journal-title":"J Invest Dermatol"},{"issue":"6","key":"3387_CR26","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1523\/jneurosci.5249-09.2010","volume":"30","author":"VS Ten","year":"2010","unstructured":"Ten VS, Yao J, Ratner V, Sosunov S, Fraser DA, Botto M, et al. Complement component C1q mediates mitochondria-driven oxidative stress in neonatal hypoxic-ischemic brain injury. J Neurosci. 2010;30(6):2077\u201387. https:\/\/doi.org\/10.1523\/jneurosci.5249-09.2010. (Epub 2010\/02\/12.).","journal-title":"J Neurosci"},{"issue":"40","key":"3387_CR27","doi-asserted-by":"publisher","first-page":"34941","DOI":"10.1074\/jbc.M111.286427","volume":"286","author":"G Chen","year":"2011","unstructured":"Chen G, Tan CS, Teh BK, Lu J. Molecular mechanisms for synchronized transcription of three complement C1q subunit genes in dendritic cells and macrophages. J Biol Chem. 2011;286(40):34941\u201350. https:\/\/doi.org\/10.1074\/jbc.M111.286427. (Epub 2011\/08\/25).","journal-title":"J Biol Chem"},{"key":"3387_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.620427","volume":"12","author":"KG Kov\u00e1cs","year":"2021","unstructured":"Kov\u00e1cs KG, M\u00e1csik-Valent B, Matk\u00f3 J, Bajtay Z, Erdei A. Revisiting the coreceptor function of complement receptor type 2 (CR2, CD21); coengagement with the B-cell receptor inhibits the activation, proliferation, and antibody production of human B cells. Front Immunol. 2021;12:620427. https:\/\/doi.org\/10.3389\/fimmu.2021.620427. (Epub 2021\/04\/20.).","journal-title":"Front Immunol"},{"issue":"5","key":"3387_CR29","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.molimm.2008.09.026","volume":"46","author":"R Khera","year":"2009","unstructured":"Khera R, Das N. Complement receptor 1: disease associations and therapeutic implications. Mol Immunol. 2009;46(5):761\u201372. https:\/\/doi.org\/10.1016\/j.molimm.2008.09.026. (Epub 2008\/11\/14.).","journal-title":"Mol Immunol"},{"key":"3387_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells8111419","author":"B Dewidar","year":"2019","unstructured":"Dewidar B, Meyer C, Dooley S, Meindl-Beinker AN. TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis-updated 2019. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8111419. (Epub 2019\/11\/14.).","journal-title":"Cells"},{"issue":"7","key":"3387_CR31","doi-asserted-by":"publisher","first-page":"11616","DOI":"10.1002\/jcb.28441","volume":"120","author":"B Xu","year":"2019","unstructured":"Xu B, Lv W, Li X, Zhang L, Lin J. Prognostic genes of hepatocellular carcinoma based on gene coexpression network analysis. J Cell Biochem. 2019;120(7):11616\u201323. https:\/\/doi.org\/10.1002\/jcb.28441. (Epub 2019\/02\/19.).","journal-title":"J Cell Biochem"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03387-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03387-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03387-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:28:54Z","timestamp":1763738934000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03387-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3387"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03387-5","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was granted by the relevant local ethics committees. Research involving the UK Biobank cohort was conducted under the general approval of the NHS National Research Ethics Service.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1155"}}